ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hepatocellular carcinoma"

  • 2016 American Transplant Congress

    Intraoperative Blood Loss Is a Promoter of Early Tumor Recurrence in Liver Transplant Patients with High Risk Hepatocellular Carcinoma.

    A. Kornberg,1 U. Witt,1 J. Kornberg,2 H. Friess,1 K. Müller,3 K. Thrum.4

    1Surgery, Technical University, Munich, Germany; 2Anesthesiology, Ludwig-Maximilians-University, Munich, Germany; 3FSU, Jena, Germany; 4Pathology, Helios-Klinikum, Berlin, Germany.

    Background:Currently, there is an increasing body of evidence that risk of early hepatocellular carcinoma (HCC) relapse following liver transplantation (LT) may be promoted by mechanisms…
  • 2016 American Transplant Congress

    Traditionally Unacceptable Organs Promote Liver Transplantation in Patients with Long Waiting Times in the Share 35 Era.

    E. Siskind,1 T. MacDonald,2 R. Barth,1 J. LaMattina,1 D. Bruno,1 S. Hanish.1

    1Department of Surgery, University of Maryland School of Medicine, Baltimore, MD; 2University of Maryland Medical Center, Baltimore, MD.

    Hepatocellular carcinoma (HCC) remains the most commonly granted MELD exception (M/E). Share 35 has disadvantaged this population. We have developed a strategy to use traditionally…
  • 2016 American Transplant Congress

    Comparative Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma (HCC-CCA) Undergoing Liver Transplantation: A Single Center Matched Cohort Analysis.

    K. Lunsford, M. Harlander-Locke, J. Gornbein, A. Zarrinpar, F. Kaldas, H. Yersiz, D. Farmer, R. Busuttil, V. Agopian.

    Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA.

    Liver transplant (LT) is the gold standard for hepatocellular carcinoma (HCC) but is contraindicated in known HCC-CCA due to poor prognosis. We compared posttransplant oncologic…
  • 2016 American Transplant Congress

    Hepatocellular Carcinoma Decreases Chance of Successful HCV Therapy in the Current Era.

    S. Prenner, L. VanWagner, L. Kulik.

    Gastroenterology and Hepatology, Northwestern University, Chicago, IL.

    Background: The efficacy of direct acting antiviral agents (DAA) for hepatitis C (HCV) in patients with hepatocellular carcinoma (HCC) is limited. We hypothesized that virology…
  • 2016 American Transplant Congress

    Clinical Analysis of Patients with Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation.

    D. Kim, G. Na, T. Hong, Y. You.

    Surgery, Seoul St. Mary's Hospital, Catholic University, Seoul, Korea.

    Purpose: For living-donor liver transplantation (LDLT), there has been a tendency to accept extended criteria in comparison with deceased-donor liver transplantation (DDLT). However, HCC recurrence…
  • 2016 American Transplant Congress

    Is Pretransplant Determination of Hepatocellular Carcinoma Tumor Grade Using Needle Biopsy Reliable for Transplant Candidate Selection? Analysis of 217 Liver Transplant Recipients.

    C. Court, M. Harlander-Locke, D. Markovic, F. Kaldas, A. Zarrinpar, D. Farmer, S. Sho, J. Tomlinson, J. Hiatt, R. Busuttil, V. Agopian, D. Lu, S. Raman.

    Department of Surgery, UCLA, Los Angeles, CA.

    Objective: Despite the prognostic significance of tumor grade and vascular invasion for patients with hepatocellular carcinoma (HCC), preoperative needle biopsy (PNB) is not routinely utilized…
  • 2016 American Transplant Congress

    Predictive Value of Preoperation Serum Gamma-Glutamyltranspeptidase for Hepatocellular Carcinoma Prognosis After Liver Transplantation.

    S. Fu, Q. Zhao, M. Chen, L. Wu, Q. Ren, F. Ji, Z. Guo, X. He.

    Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

    Objectives: The aims of this study were to evaluate the prognostic value of preoperative serum gamma-glutamyltranspeptidase (γ-GGT) in patients with hepatocellular carcinoma (HCC) underwent liver…
  • 2016 American Transplant Congress

    The Influence of Rising Lab MELD on Vascular Invasion in HCC.

    K. Halazun, E. Przybyszewski, E. Verna, B. Samstein, A. Fox, R. Brown, J. Emond.

    Liver Transplant & HPB Surgery, Weill Cornell Medical College, NY, NY.

    Background Vascular invasion (VI) is one of the most important predictors of HCC recurrence. Although attempts to identify predictors of VI have been made, datasets…
  • 2015 American Transplant Congress

    Clinical Impact of 18F-FDG-PET/CT in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma

    S. Lee, S. Kim.

    Liver Cancer Center, National Cancer Center, Goyang, Korea.

    Background: The relevant number of patients with hepatocellular carcinoma (HCC) beyond the Milan criteria has undergone living donor liver transplantation (LDLT). However, the prognostic factors…
  • 2015 American Transplant Congress

    Predictors of Time to Recurrence and Mortality Associated With Recurrent Hepatocellular Carcinoma After Liver Transplantation

    A. Bodzin, D. Reino, K. Lunsford, M. Harlander-Locke, D. Markovich, A. Zarrinpar, F. Kaldas, D. Farmer, R. Busuttil, V. Agopian.

    Transplantation, UCLA, Los Angeles, CA.

    Background: While recurrent hepatocellular carcinoma (HCC) after liver transplantation (LT) portends a poor prognosis, adjuvant therapy may prolong survival. We sought to identify factors that…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences